SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
November 19, 2002
CONNETICS CORPORATION
| Delaware | 0-27406 | 94-3173928 | ||
|
|
||||
| (State or Other Jurisdiction of Incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
3290 West Bayshore Road, Palo Alto, California 94303
(650) 843-2800
1
| Item 5. Other Events. | ||||||||
| Item 7. Financial Statements, ProForma Financial Information and Exhibits. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. Other Events.
On November 19, 2002, Connetics Corporation announced that it has in-licensed the right to access the clinical, regulatory and manufacturing records of a currently approved and marketed dermatological product. Connetics intends to reformulate and market the product using its proprietary foam delivery vehicle. Details regarding the product and the target market were not disclosed.
A copy of the press release announcing this event is attached to this Report as Exhibit 99.1 and is incorporated into this report by this reference.
Item 7. Financial Statements, ProForma Financial Information and Exhibits.
(c) Exhibits.
| 99.1 | Press Release dated November 19, 2002. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CONNETICS CORPORATION | ||
| By: | /s/ Katrina J. Church | |
| Katrina J. Church Executive Vice President, Legal Affairs General Counsel and Secretary |
||
Date: November 20, 2002
3
EXHIBIT INDEX
| Exhibit | ||
| Number | Description | |
| 99.1 | Press Release dated November 19, 2002 |